Sphera Funds Management Ltd. Madrigal Pharmaceuticals, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $2.78 Million - $5.48 Million	-23,100 Reduced 45.41%	27,767 $6.42 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $3.78 Million - $5.84 Million	25,867 Added 103.47%	50,867 $7.43 Million
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $1.22 Million - $1.87 Million	6,000 Added 31.58%	25,000 $5.78 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $4.39 Million - $5.83 Million	19,000 New	19,000 $4.6 Million

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.37B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.